Showing results (1-10 of 133) with videos related to
Sort By:
Pageof 14
Journal of Gastroenterology|November 29, 2012
Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelinesKazuaki Chayama, C Nelson Hayes, Waka Ohishi, et al.Antiviral Therapy|November 7, 2013
Telaprevir is effective given every 12 h at 750 mg with pegylated interferon-α2b and ribavirin to Japanese patients with HCV-1b IL28B rs8099917 TTYoshiiku Kawakami, Fumitaka Suzuki, Yoshiyasu Karino, et al.American Journal of Surgery|October 2, 2002
Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinomaKoji Kamada, Mikiya Kitamoto, Hiroshi Aikata, et al.Clinical Journal of Gastroenterology|July 21, 2015
Use of entecavir to prevent hepatitis B virus reactivation during cytotoxic chemotherapy for solid malignancyRiki Okita, Mamoru Takahashi, Hiroyuki Narahara, et al.Journal of Medical Virology|February 26, 2004
Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clampingWaka Ohishi, Hiroo Shirakawa, Yoshiiku Kawakami, et al.Plos One|December 8, 2017
HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patientsLaetitia Canini, Michio Imamura, Yoshiiku Kawakami, et al.Journal of Medical Virology|February 25, 2009
Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapyNami Mori, Michio Imamura, Yoshiiku Kawakami, et al.Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 9, 2014
A case of syndrome of inappropriate secretion of antidiuretic hormone following transarterial embolization with cisplatinHiromi Kan, Tomokazu Kawaoka, Tomoki Kobayashi, et al.Oncology|August 23, 2008
Combination therapy of oral fluoropyrimidine anticancer drug S-1 and interferon alpha for HCC patients with extrahepatic metastasesKiminori Uka, Hiroshi Aikata, Nami Mori, et al.Hepato-Gastroenterology|March 18, 2011
Pilot study of systemic combination therapy with S-1, an oral fluoropyrimidine, and cisplatin for hepatocellular carcinoma with extrahepatic metastasesYoshio Katamura, Hiroshi Aikata, Yoshimasa Hashimoto, et al.Pageof 14